Floriane Simonne Tissot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Floriane Simonne Tissot has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Chloe C. Feral
INSERM, CNRS, IRCAN, Université Côte d'Azur, Nice, France
9 shared publications Laurence Cailleteau
INSERM U1081, CNRS UMR7284, UCA, IRCAN, Nice, France
6 shared publications- Cristina Lo Celso
Imperial College London, London, United Kingdom
5 shared publications - Etienne Boulter
INSERM
5 shared publications Lionel Tosello
Université Côte d’Azur, INSERM, CNRS, IRCAN, 06107 Nice, France
4 shared publicationsCera Mai
Imperial College London, London, United Kingdom
3 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by American Society of Hematology in Blood
Rare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation
Hematopoietic stem cells (HSCs) sustain lifelong hematopoiesis as their progeny differentiate into all blood cell lineages. Homeostatic HSCs are mostly quiescent and only rarely divide, however their proliferation and differentiation rates can be modulated by external factors. Acute and chronic infections from a wide range of pathogens are known to challenge HSCs at the population level, being forced to respond to inflammation-mediated organismal demand to replenish the myeloid cell pool. However, less is known about the degree of heterogeneity in the HSCs' response to inflammation at the single cell level. Here, using a natural murine malaria model and an NHS-ester biotin dilution assay we identify two subsets of HSCs, BiotinLo and BiotinHi, with distinct proliferation kinetics. Using combined functional, single-cell transcriptomics and phenotypic analyses, we uncover that BiotinHi HSCs remain highly functional despite expressing strong interferon response signatures. These resilient HSCs are more poised to enter cell cycle than control HSCs, but do not divide. They maintain less active mitochondria and express higher levels of CD74 and MHC-II. Additionally, they express higher levels of integrin β2/CD18, which suggest they may have specific interactions with the bone marrow microenvironment. Similar patterns of NHS-ester biotin dilution were elicited by LPS and poly (I:C) challenges. These findings highlight previously unmeasured heterogeneity in the response of HSCs to acute infection-induced inflammation and demonstrate that a likely reserve pool of HSCs remains highly functional during Plasmodium infection not because cells are shielded, but because they maintain a stemness associated metabolic profile despite effectively sensing inflammation.
- 30 September 2026
- Published by American Society of Hematology in Blood
Open AccessRare Hematopoietic Stem Cells resilient to infection-induced stress sense yet withstand inflammation
Hematopoietic stem cells (HSCs) sustain lifelong hematopoiesis as their progeny differentiate into all blood cell lineages. Homeostatic HSCs are mostly quiescent and only rarely divide, however their proliferation and differentiation rates can be modulated by external factors. Acute and chronic infections from a wide range of pathogens are known to challenge HSCs at the population level, being forced to respond to inflammation-mediated organismal demand to replenish the myeloid cell pool. However, less is known about the degree of heterogeneity in the HSCs' response to inflammation at the single cell level. Here, using a natural murine malaria model and an NHS-ester biotin dilution assay we identify two subsets of HSCs, BiotinLo and BiotinHi, with distinct proliferation kinetics. Using combined functional, single-cell transcriptomics and phenotypic analyses, we uncover that BiotinHi HSCs remain highly functional despite expressing strong interferon response signatures. These resilient HSCs are more poised to enter cell cycle than control HSCs, but do not divide. They maintain less active mitochondria and express higher levels of CD74 and MHC-II. Additionally, they express higher levels of integrin β2/CD18, which suggest they may have specific interactions with the bone marrow microenvironment. Similar patterns of NHS-ester biotin dilution were elicited by LPS and poly (I:C) challenges. These findings highlight previously unmeasured heterogeneity in the response of HSCs to acute infection-induced inflammation and demonstrate that a likely reserve pool of HSCs remains highly functional during Plasmodium infection not because cells are shielded, but because they maintain a stemness associated metabolic profile despite effectively sensing inflammation.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Rôle de CD98hc dans les fibroblastes dermiques au cours de l’homéostasie et de la tumorigenèse cutanées
L’interaction épithélium/mésenchyme est cruciale pour de nombreux processus physiopathologiques. Lors de ma thèse, je me suis intéressée aux signaux mésenchymateux régulant les cellules épithéliales en utilisant comme modèle la peau, qui est composée de 2 compartiments : l’épiderme (épithélium) et le derme (mésenchyme). Les intégrines sont impliquées ces interactions. CD98hc est une protéine transmembranaire à double fonction qui chaperonne des transporteurs d’acides aminés et régule la signalisation des ß intégrines. Elle est exprimée dans les cellules prolifératives telle les cellules épithéliales. Dans la peau, CD98hc est exprimée l’épiderme mais également dans les fibroblastes, cellules post-mitotiques. Mon hypothèse a été que CD98hc participe aux régulations des interactions derme/épiderme. Grâce à un modèle de KO conditionnel de CD98hc dans les fibroblastes dermiques, j’ai mis en évidence que CD98hc permet le maintient des propriétés mécaniques et biologiques du derme, et, de ce fait, régule l’épiderme en conditions d’homéostasie, de perturbation de la barrière et lors de la formation de cancer. De plus, le rôle de CD98hc dans cette interaction apparait comme étant lié à l’âge. En conclusion, mes travaux de thèse montrent le rôle central de l’expression dermique de CD98hc dans le maintien de l’homéostasie cutanée au cours du vieillissement ainsi que lors de la tumorigenèse.
- 3 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Rôle de CD98hc dans les fibroblastes dermiques au cours de l’homéostasie et de la tumorigenèse cutanées
L’interaction épithélium/mésenchyme est cruciale pour de nombreux processus physiopathologiques. Lors de ma thèse, je me suis intéressée aux signaux mésenchymateux régulant les cellules épithéliales en utilisant comme modèle la peau, qui est composée de 2 compartiments : l’épiderme (épithélium) et le derme (mésenchyme). Les intégrines sont impliquées ces interactions. CD98hc est une protéine transmembranaire à double fonction qui chaperonne des transporteurs d’acides aminés et régule la signalisation des ß intégrines. Elle est exprimée dans les cellules prolifératives telle les cellules épithéliales. Dans la peau, CD98hc est exprimée l’épiderme mais également dans les fibroblastes, cellules post-mitotiques. Mon hypothèse a été que CD98hc participe aux régulations des interactions derme/épiderme. Grâce à un modèle de KO conditionnel de CD98hc dans les fibroblastes dermiques, j’ai mis en évidence que CD98hc permet le maintient des propriétés mécaniques et biologiques du derme, et, de ce fait, régule l’épiderme en conditions d’homéostasie, de perturbation de la barrière et lors de la formation de cancer. De plus, le rôle de CD98hc dans cette interaction apparait comme étant lié à l’âge. En conclusion, mes travaux de thèse montrent le rôle central de l’expression dermique de CD98hc dans le maintien de l’homéostasie cutanée au cours du vieillissement ainsi que lors de la tumorigenèse.
- Open Access
- 13 March 2026
- Published by Elsevier in Cell Reports Methods
- Vol. 6 (3) , 101334
Practical AI-based cell extraction and spatial statistics for large 3D bone marrow tissue images
- 13 March 2026
- Published by Elsevier in Cell Reports Methods
- Vol. 6 (3) , 101334
Open AccessPractical AI-based cell extraction and spatial statistics for large 3D bone marrow tissue images
- Open Access
- 12 December 2024
- Published by Elsevier in Matrix Biology
- Vol. 135, 99-105
Functional transfer of integrin co-receptor CD98hc by small extracellular vesicles improves wound healing in vivo
- 12 December 2024
- Published by Elsevier in Matrix Biology
- Vol. 135, 99-105
Open AccessFunctional transfer of integrin co-receptor CD98hc by small extracellular vesicles improves wound healing in vivo
- Open Access
SIRPα+ PD-L1+ bone marrow macrophages aid AML growth by modulating T cell function
Acute myeloid leukemia (AML) continues to have a poor prognosis due to its ability to relapse following initial response to chemotherapy. While immunotherapies hold the promise to revolutionize cancer treatment, AML has been particularly challenging to target. It is therefore important to better understand the relationship between AML cells and immune cells within the bone marrow (BM) microenvironment, where this disease grows. Here we focus on non-malignant BM macrophages, and using a combination of intravital microscopy, flow cytometry, transcriptomics and functional analyses we identify a subpopulation of immunomodulatory BM macrophages (IMMs) with a unique profile and function during AML progression. While the majority of macrophages are already being lost at early infiltration, IMMs are locally enriched. They are capable of efferocytosis and support AML growth through inhibition of T cells. Enrichment of IMMs in the BM of patients developing early relapse indicates that future development of interventions that target IMMs’ development and function may improve AML patients’ outcome.
Open AccessSIRPα+ PD-L1+ bone marrow macrophages aid AML growth by modulating T cell function
Acute myeloid leukemia (AML) continues to have a poor prognosis due to its ability to relapse following initial response to chemotherapy. While immunotherapies hold the promise to revolutionize cancer treatment, AML has been particularly challenging to target. It is therefore important to better understand the relationship between AML cells and immune cells within the bone marrow (BM) microenvironment, where this disease grows. Here we focus on non-malignant BM macrophages, and using a combination of intravital microscopy, flow cytometry, transcriptomics and functional analyses we identify a subpopulation of immunomodulatory BM macrophages (IMMs) with a unique profile and function during AML progression. While the majority of macrophages are already being lost at early infiltration, IMMs are locally enriched. They are capable of efferocytosis and support AML growth through inhibition of T cells. Enrichment of IMMs in the BM of patients developing early relapse indicates that future development of interventions that target IMMs’ development and function may improve AML patients’ outcome.
- Open Access
PACESS: Practical AI-based Cell Extraction and Spatial Statistics for large 3D bone marrow tissue images
/SUMMARY: Despite much being known about the molecular regulation of hematopoiesis, little is understood about how hematopoietic cells are organized within bone marrow (BM) tissue. Recent advances in microscopy have led to the creation of increasingly detailed images of murine hematopoietic tissue. Accurate, efficient, and informative methodologies to extract and analyze the large amount of data generated are, however, still lacking. Indeed, cells are very densely packed in the bone marrow and therefore difficult to efficiently and accurately segment. In addition, currently employed statical analyses of cellular localization are generally unsuitable for the investigation of interactions between more than two cell types. To overcome these limitations, we developed PACESS, a readily applicable method based on neural network classification of hundreds of thousands of cells in thick 3D bone marrow samples, and a combination of statistical techniques to assess the spatial interactions between multiple cell types. To validate this approach, we used it to investigate the spatial organization of T cells, megakaryocytes and leukemic cells. We demonstrate that the presence of large clusters of leukemic cells affects the distribution of both T cells and megakaryocytes, albeit differently, resulting in the generation of previously unrecognized, unique microenvironments adjacent to each other within the same bone marrow cavity. We believe that this approach can contribute to unravel the BM cellular organization. MOTIVATION: The organization of diverse hematopoietic cells within bone marrow tissue remains unclear. Recently developed tissue clearing methods enable the generation of large, 3D, single cell resolution microscopy images datasets, but the bottleneck in their analysis lies in both the identification and classification of cells, and in statistical analyses to probe their spatial relationships. We present a workflow (PACESS) that takes advantage of a convoluted neural network to identify and classify cells in 2D coupled with an automated method that extrapolates to 3D, followed by a combination of spatial statistics to classify tissue regions based on each cell type’s density, and logistic regression to test whether the relative abundance of cell types may be explained by reciprocal dependencies. Finally, we provide a combined measurement of the abundance of all cell types in a 3D map, highlighting regional variations found within the tissue. Graphical
Open AccessPACESS: Practical AI-based Cell Extraction and Spatial Statistics for large 3D bone marrow tissue images
/SUMMARY: Despite much being known about the molecular regulation of hematopoiesis, little is understood about how hematopoietic cells are organized within bone marrow (BM) tissue. Recent advances in microscopy have led to the creation of increasingly detailed images of murine hematopoietic tissue. Accurate, efficient, and informative methodologies to extract and analyze the large amount of data generated are, however, still lacking. Indeed, cells are very densely packed in the bone marrow and therefore difficult to efficiently and accurately segment. In addition, currently employed statical analyses of cellular localization are generally unsuitable for the investigation of interactions between more than two cell types. To overcome these limitations, we developed PACESS, a readily applicable method based on neural network classification of hundreds of thousands of cells in thick 3D bone marrow samples, and a combination of statistical techniques to assess the spatial interactions between multiple cell types. To validate this approach, we used it to investigate the spatial organization of T cells, megakaryocytes and leukemic cells. We demonstrate that the presence of large clusters of leukemic cells affects the distribution of both T cells and megakaryocytes, albeit differently, resulting in the generation of previously unrecognized, unique microenvironments adjacent to each other within the same bone marrow cavity. We believe that this approach can contribute to unravel the BM cellular organization. MOTIVATION: The organization of diverse hematopoietic cells within bone marrow tissue remains unclear. Recently developed tissue clearing methods enable the generation of large, 3D, single cell resolution microscopy images datasets, but the bottleneck in their analysis lies in both the identification and classification of cells, and in statistical analyses to probe their spatial relationships. We present a workflow (PACESS) that takes advantage of a convoluted neural network to identify and classify cells in 2D coupled with an automated method that extrapolates to 3D, followed by a combination of spatial statistics to classify tissue regions based on each cell type’s density, and logistic regression to test whether the relative abundance of cell types may be explained by reciprocal dependencies. Finally, we provide a combined measurement of the abundance of all cell types in a 3D map, highlighting regional variations found within the tissue. Graphical
- Open Access
- 20 May 2022
- Published by American Society of Hematology in Blood Advances
- Vol. 6 (10) , 3126-3141
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness
Acute myeloid leukemia (AML) is a blood cancer of the myeloid lineage. Its prognosis remains poor, highlighting the need for new therapeutic and precision medicine approaches. AML symptoms often include cytopenias linked to loss of healthy hematopoietic stem and progenitor cells (HSPCs). The mechanisms behind HSPC decline are complex and still poorly understood. Here, intravital microscopy (IVM) of a well-established experimental model of AML allows direct observation of the interactions between healthy and malignant cells in the bone marrow (BM), suggesting that physical dislodgment of healthy cells by AML through damaged vasculature may play an important role. Multiple matrix metalloproteinases (MMPs), known to remodel extracellular matrix, are expressed by AML cells and the BM microenvironment. We reason MMPs could be involved in cell displacement and vascular leakiness; therefore, we evaluate the therapeutic potential of MMP pharmacological inhibition using the broad-spectrum inhibitor prinomastat. IVM analyses of prinomastat-treated mice reveal reduced vascular permeability and healthy cell clusters in circulation and lower AML infiltration, proliferation, and cell migration. Furthermore, treated mice have increased retention of healthy HSPCs in the BM and increased survival following chemotherapy. Analysis of a human AML transcriptomic database reveals widespread MMP deregulation, and human AML cells show susceptibility to MMP inhibition. Overall, our results suggest that MMP inhibition could be a promising complementary therapy to reduce AML growth and limit HSPC loss and BM vascular damage caused by MLL-AF9 and possibly other AML subtypes.
- 20 May 2022
- Published by American Society of Hematology in Blood Advances
- Vol. 6 (10) , 3126-3141
Open AccessMetalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectiveness
Acute myeloid leukemia (AML) is a blood cancer of the myeloid lineage. Its prognosis remains poor, highlighting the need for new therapeutic and precision medicine approaches. AML symptoms often include cytopenias linked to loss of healthy hematopoietic stem and progenitor cells (HSPCs). The mechanisms behind HSPC decline are complex and still poorly understood. Here, intravital microscopy (IVM) of a well-established experimental model of AML allows direct observation of the interactions between healthy and malignant cells in the bone marrow (BM), suggesting that physical dislodgment of healthy cells by AML through damaged vasculature may play an important role. Multiple matrix metalloproteinases (MMPs), known to remodel extracellular matrix, are expressed by AML cells and the BM microenvironment. We reason MMPs could be involved in cell displacement and vascular leakiness; therefore, we evaluate the therapeutic potential of MMP pharmacological inhibition using the broad-spectrum inhibitor prinomastat. IVM analyses of prinomastat-treated mice reveal reduced vascular permeability and healthy cell clusters in circulation and lower AML infiltration, proliferation, and cell migration. Furthermore, treated mice have increased retention of healthy HSPCs in the BM and increased survival following chemotherapy. Analysis of a human AML transcriptomic database reveals widespread MMP deregulation, and human AML cells show susceptibility to MMP inhibition. Overall, our results suggest that MMP inhibition could be a promising complementary therapy to reduce AML growth and limit HSPC loss and BM vascular damage caused by MLL-AF9 and possibly other AML subtypes.
- Open Access
Fibronectin meshwork controls epithelial stem cell fate
Adult stem cell fate is tightly balanced by the local microenvironment called niche and sustain tissue regeneration 1–4 . How niche signals are integrated and regulate regeneration remains largely unexplored. The extracellular matrix and integrin ligand fibronectin is a crucial and well-characterized wound healing actor that has never been involved in skin regeneration. Here, we show that fibronectin displays a highly specific enrichment in hair follicle stem cells (HFSC) at the onset of regeneration. Conditional deletion of fibronectin in HFSC compartment (Lrig1, K19) leads to hair regeneration blockade, impaired stem cell location and fate. Dermal injection of exogenous fibronectin rescues these phenotypes. To elucidate molecular mechanism underlying fibronectin function, we used conditional deletion models of SLC3A2, the main integrin coreceptor. We show that, via its role in integrin-dependent assembly of fibronectin matrix, SLC3A2 acts as molecular relay of niche signals. Thus, fibronectin-integrin-SLC3A2 cascade finely tunes HFSC fate and tissue regenerative power.
Open AccessFibronectin meshwork controls epithelial stem cell fate
Adult stem cell fate is tightly balanced by the local microenvironment called niche and sustain tissue regeneration 1–4 . How niche signals are integrated and regulate regeneration remains largely unexplored. The extracellular matrix and integrin ligand fibronectin is a crucial and well-characterized wound healing actor that has never been involved in skin regeneration. Here, we show that fibronectin displays a highly specific enrichment in hair follicle stem cells (HFSC) at the onset of regeneration. Conditional deletion of fibronectin in HFSC compartment (Lrig1, K19) leads to hair regeneration blockade, impaired stem cell location and fate. Dermal injection of exogenous fibronectin rescues these phenotypes. To elucidate molecular mechanism underlying fibronectin function, we used conditional deletion models of SLC3A2, the main integrin coreceptor. We show that, via its role in integrin-dependent assembly of fibronectin matrix, SLC3A2 acts as molecular relay of niche signals. Thus, fibronectin-integrin-SLC3A2 cascade finely tunes HFSC fate and tissue regenerative power.
- 1 January 2020
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 133 (1)
Cyclic uniaxial mechanical stretching of cells using a LEGO® parts-based mechanical stretcher system
Mechanical cues are essential for the regulation of cell and tissue physiology. Hence, it has become an utmost necessity for cell biologists to account for those mechanical parameters when investigating biological processes and they need devices to manipulate cells accordingly. Here, we report a simple mechanical cell-stretching system that can generate uniaxial cyclic mechanical stretch on cells in tissue culture. This system is based upon a low-cost battery-powered uniaxial cyclic mechanical stretcher exclusively built out of LEGO® parts combined with a stretchable poly(dimethylsiloxane) tissue culture plate in order to grow and stretch cells. We characterize the system and show that it can be used in a wide variety of downstream applications, including immunofluorescence, western blotting and biochemical assays. We also illustrate how this system can be useful in a study as we investigated the behavior of integrin adhesion complexes upon cell stretching. We therefore present a cost-effective, multipurpose cell-stretching system that should help to increase understanding of mechanical signaling. This article has an associated First Person interview with the first author of the paper.
- 1 January 2020
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 133 (1)
Cyclic uniaxial mechanical stretching of cells using a LEGO® parts-based mechanical stretcher system
Mechanical cues are essential for the regulation of cell and tissue physiology. Hence, it has become an utmost necessity for cell biologists to account for those mechanical parameters when investigating biological processes and they need devices to manipulate cells accordingly. Here, we report a simple mechanical cell-stretching system that can generate uniaxial cyclic mechanical stretch on cells in tissue culture. This system is based upon a low-cost battery-powered uniaxial cyclic mechanical stretcher exclusively built out of LEGO® parts combined with a stretchable poly(dimethylsiloxane) tissue culture plate in order to grow and stretch cells. We characterize the system and show that it can be used in a wide variety of downstream applications, including immunofluorescence, western blotting and biochemical assays. We also illustrate how this system can be useful in a study as we investigated the behavior of integrin adhesion complexes upon cell stretching. We therefore present a cost-effective, multipurpose cell-stretching system that should help to increase understanding of mechanical signaling. This article has an associated First Person interview with the first author of the paper.
- Open Access
- 19 November 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-15
Cell metabolism regulates integrin mechanosensing via an SLC3A2-dependent sphingolipid biosynthesis pathway
Mechanical and metabolic cues independently contribute to the regulation of cell and tissue homeostasis. However, how they cross-regulate each other during this process remains largely unknown. Here, we show that cellular metabolism can regulate integrin rigidity-sensing via the sphingolipid metabolic pathway controlled by the amino acid transporter and integrin coreceptor CD98hc (SLC3A2). Genetic invalidation of CD98hc in dermal cells and tissue impairs rigidity sensing and mechanical signaling downstream of integrins, including RhoA activation, resulting in aberrant tissue mechanical homeostasis. Unexpectedly, we found that this regulation does not occur directly through regulation of integrins by CD98hc but indirectly, via the regulation of sphingolipid synthesis and the delta-4-desaturase DES2. Loss of CD98hc decreases sphingolipid availability preventing proper membrane recruitment, shuttling and activation of upstream regulators of RhoA including Src kinases and GEF-H1. Altogether, our results unravel a novel cross-talk regulation between integrin mechanosensing and cellular metabolism which may constitute an important new regulatory framework contributing to mechanical homeostasis.
- 19 November 2018
- Published by Springer Nature in Nature Communications
- Vol. 9 (1) , 1-15
Open AccessCell metabolism regulates integrin mechanosensing via an SLC3A2-dependent sphingolipid biosynthesis pathway
Mechanical and metabolic cues independently contribute to the regulation of cell and tissue homeostasis. However, how they cross-regulate each other during this process remains largely unknown. Here, we show that cellular metabolism can regulate integrin rigidity-sensing via the sphingolipid metabolic pathway controlled by the amino acid transporter and integrin coreceptor CD98hc (SLC3A2). Genetic invalidation of CD98hc in dermal cells and tissue impairs rigidity sensing and mechanical signaling downstream of integrins, including RhoA activation, resulting in aberrant tissue mechanical homeostasis. Unexpectedly, we found that this regulation does not occur directly through regulation of integrins by CD98hc but indirectly, via the regulation of sphingolipid synthesis and the delta-4-desaturase DES2. Loss of CD98hc decreases sphingolipid availability preventing proper membrane recruitment, shuttling and activation of upstream regulators of RhoA including Src kinases and GEF-H1. Altogether, our results unravel a novel cross-talk regulation between integrin mechanosensing and cellular metabolism which may constitute an important new regulatory framework contributing to mechanical homeostasis.